CJC-1295 (without DAC) and TB-500 Interaction

Synergistic
Mechanism-based 47% confidence

CJC-1295 (without DAC) and TB-500 have a synergistic interaction with 47% confidence. CJC-1295 (without DAC) and TB-500 work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. These compounds primarily affect different organ systems.

Compound Profiles

CJC-1295 (without DAC)

Short-Acting Growth Hormone Releasing Hormone Analog

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

Half-life: 30 minutes - 2 hours Typical dose: 100-300mcg per injection growth hormone, weight loss
ghrh receptor carcinogenic riskestrogenicinsulin disruptingteratogenic
View full profile

TB-500

Synthetic Fragment (17-23) of Thymosin Beta-4

Acts as principal actin-sequestering protein, regulating cell migration, promoting angiogenesis, reducing inflammation, and activating stem cell differentiation for comprehensive regenerative effects..

Half-life: ~2 hours Typical dose: 2-5mg per injection (higher doses for serious injuries) healing, longevity
carcinogenic riskteratogenic
View full profile

Combined Organ Load

GI Tract
low
Pituitary
low
Blood Vessels
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (CJC-1295 (without DAC), TB-500). Monitor accordingly.
2x 2 compounds share the teratogenic safety flag (CJC-1295 (without DAC), TB-500). Monitor accordingly.

Frequently Asked Questions

Can I take CJC-1295 (without DAC) with TB-500?

Yes, CJC-1295 (without DAC) and TB-500 can generally be taken together. CJC-1295 (without DAC) and TB-500 work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is CJC-1295 (without DAC) and TB-500 safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: carcinogenic risk, teratogenic. Monitor accordingly.

What are the interactions between CJC-1295 (without DAC) and TB-500?

CJC-1295 (without DAC) and TB-500 work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time CJC-1295 (without DAC) and TB-500?

CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours and TB-500 has a half-life of ~2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: CJC-1295 (without DAC) vs TB-500

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.